| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |